Join Growin Stock Community!

The clorox companyCLX.US Overview

US StockConsumer Defensive
(No presentation for CLX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CLX AI Insights

CLX Overall Performance

CLX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CLX Recent Performance

-0.54%

The clorox company

-1.34%

Avg of Sector

-0.31%

S&P500

CLX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CLX Key Information

CLX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CLX Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.

Price of CLX

CLX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CLX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
6.19
PE Ratio (TTM)
20.85
Forward PE
16.99
PS Ratio (TTM)
2.30
PB Ratio
41.40
Price-to-FCF
19.83
METRIC
VALUE
vs. INDUSTRY
Gross Margin
44.18%
Net Margin
11.17%
Revenue Growth (YoY)
-5.68%
Profit Growth (YoY)
-6.54%
3-Year Revenue Growth
-0.82%
3-Year Profit Growth
5.21%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
6.19
PE Ratio (TTM)
20.85
Forward PE
16.99
PS Ratio (TTM)
2.30
PB Ratio
41.40
Price-to-FCF
19.83
Gross Margin
44.18%
Net Margin
11.17%
Revenue Growth (YoY)
-5.68%
Profit Growth (YoY)
-6.54%
3-Year Revenue Growth
-0.82%
3-Year Profit Growth
5.21%

  • When is CLX's latest earnings report released?

    The most recent financial report for The clorox company (CLX) covers the period of 2026Q2 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CLX's short-term business performance and financial health. For the latest updates on CLX's earnings releases, visit this page regularly.

  • Where does CLX fall in the P/E River chart?

    According to historical valuation range analysis, The clorox company (CLX)'s current price-to-earnings (P/E) ratio is 18.41, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of CLX?

    According to the latest financial report, The clorox company (CLX) reported an Operating Profit of 240M with an Operating Margin of 14.35% this period, representing a decline of 7.34% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CLX's revenue growth?

    In the latest financial report, The clorox company (CLX) announced revenue of 1.67B, with a Year-Over-Year growth rate of -0.77%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does CLX have?

    As of the end of the reporting period, The clorox company (CLX) had total debt of 3.22B, with a debt ratio of 0.57. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CLX have?

    At the end of the period, The clorox company (CLX) held Total Cash and Cash Equivalents of 227M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CLX go with three margins increasing?

    In the latest report, The clorox company (CLX) achieved the “three margins increasing” benchmark, with a gross margin of 43.2%%, operating margin of 14.35%%, and net margin of 9.4%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CLX's profit trajectory and future growth potential.

  • Is CLX's EPS continuing to grow?

    According to the past four quarterly reports, The clorox company (CLX)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 1.29. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of CLX?

    The clorox company (CLX)'s Free Cash Flow (FCF) for the period is 269M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 111.81% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of CLX?

    The latest valuation data shows The clorox company (CLX) has a Price-To-Earnings (PE) ratio of 18.41 and a Price/Earnings-To-Growth (PEG) ratio of 0.2. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.